-+ 0.00%
-+ 0.00%
-+ 0.00%

TAKEDA RECEIVES U.S. FDA APPROVAL OF MIMRYLO™ (RUSFERTIDE), MARKING A POTENTIAL SHIFT IN THE TREATMENT PARADIGM FOR POLYCYTHEMIA VERA

Reuters·08/28/2026 22:40:00

Please log in to view news